[go: up one dir, main page]

FR2832311B1 - Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations - Google Patents

Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations

Info

Publication number
FR2832311B1
FR2832311B1 FR0115069A FR0115069A FR2832311B1 FR 2832311 B1 FR2832311 B1 FR 2832311B1 FR 0115069 A FR0115069 A FR 0115069A FR 0115069 A FR0115069 A FR 0115069A FR 2832311 B1 FR2832311 B1 FR 2832311B1
Authority
FR
France
Prior art keywords
compositions
film
same
preparation methods
forming powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0115069A
Other languages
English (en)
Other versions
FR2832311A1 (fr
Inventor
Jerome Besse
Laurence Besse
Philippe Cornu
Brigitte Taravella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Besins International Belgique
Galenix Innovations Sas
Original Assignee
Besins International Belgique
Galenix Innovations Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins International Belgique, Galenix Innovations Sas filed Critical Besins International Belgique
Priority to FR0115069A priority Critical patent/FR2832311B1/fr
Priority to US10/097,781 priority patent/US20030096012A1/en
Priority to PL02370777A priority patent/PL370777A1/xx
Priority to RU2004118487/15A priority patent/RU2314796C2/ru
Priority to BR0214254-6A priority patent/BR0214254A/pt
Priority to HU0402280A priority patent/HUP0402280A3/hu
Priority to AU2002365961A priority patent/AU2002365961B2/en
Priority to IL16211002A priority patent/IL162110A0/xx
Priority to EP02803460A priority patent/EP1450772A1/fr
Priority to CA002468018A priority patent/CA2468018A1/fr
Priority to MXPA04004791A priority patent/MXPA04004791A/es
Priority to PCT/FR2002/004000 priority patent/WO2003043612A1/fr
Priority to JP2003545293A priority patent/JP2005515185A/ja
Priority to US10/496,094 priority patent/US20050042173A1/en
Publication of FR2832311A1 publication Critical patent/FR2832311A1/fr
Application granted granted Critical
Publication of FR2832311B1 publication Critical patent/FR2832311B1/fr
Priority to NO20042367A priority patent/NO20042367L/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0115069A 2001-11-21 2001-11-21 Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations Expired - Fee Related FR2832311B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR0115069A FR2832311B1 (fr) 2001-11-21 2001-11-21 Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
US10/097,781 US20030096012A1 (en) 2001-11-21 2002-03-14 Film-forming powder, compositions containing it, methods for their preparation and their uses
PCT/FR2002/004000 WO2003043612A1 (fr) 2001-11-21 2002-11-21 Poudre filmogene micronisee comprenant une substance active
BR0214254-6A BR0214254A (pt) 2001-11-21 2002-11-21 Pó filmogênio micronizado e composição farmacêutica, cosmética ou neutracêutica
HU0402280A HUP0402280A3 (en) 2001-11-21 2002-11-21 Micronized film-forming powder, composition containing them, preparation and application thereof
AU2002365961A AU2002365961B2 (en) 2001-11-21 2002-11-21 Micronized film-forming powder comprising an active substance
IL16211002A IL162110A0 (en) 2001-11-21 2002-11-21 Micronized film-forming powder comprising an active substance
EP02803460A EP1450772A1 (fr) 2001-11-21 2002-11-21 Poudre filmogene micronisee comprenant une substance active
PL02370777A PL370777A1 (en) 2001-11-21 2002-11-21 Micronized film-forming powder comprising an active substance
MXPA04004791A MXPA04004791A (es) 2001-11-21 2002-11-21 Polvo micronizado para la formacion de peliculas que comprenden una sustancia activa.
RU2004118487/15A RU2314796C2 (ru) 2001-11-21 2002-11-21 Тонкоизмельченный пленкообразующий порошок, содержащие его композиции, способы его получения и применения
JP2003545293A JP2005515185A (ja) 2001-11-21 2002-11-21 微小化された皮膜形成粉末、これを含む組成物、これらの調製方法、およびこれらを用いる方法
US10/496,094 US20050042173A1 (en) 2001-11-21 2002-11-21 Micronized film-forming powder comprising an active substance
CA002468018A CA2468018A1 (fr) 2001-11-21 2002-11-21 Poudre filmogene micronisee comprenant une substance active
NO20042367A NO20042367L (no) 2001-11-21 2004-06-07 Mikronisert filmdannende pulver omfattende et aktivt stoff

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0115069A FR2832311B1 (fr) 2001-11-21 2001-11-21 Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations

Publications (2)

Publication Number Publication Date
FR2832311A1 FR2832311A1 (fr) 2003-05-23
FR2832311B1 true FR2832311B1 (fr) 2004-04-16

Family

ID=8869637

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0115069A Expired - Fee Related FR2832311B1 (fr) 2001-11-21 2001-11-21 Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations

Country Status (14)

Country Link
US (2) US20030096012A1 (fr)
EP (1) EP1450772A1 (fr)
JP (1) JP2005515185A (fr)
AU (1) AU2002365961B2 (fr)
BR (1) BR0214254A (fr)
CA (1) CA2468018A1 (fr)
FR (1) FR2832311B1 (fr)
HU (1) HUP0402280A3 (fr)
IL (1) IL162110A0 (fr)
MX (1) MXPA04004791A (fr)
NO (1) NO20042367L (fr)
PL (1) PL370777A1 (fr)
RU (1) RU2314796C2 (fr)
WO (1) WO2003043612A1 (fr)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
IL152289A0 (en) * 2002-10-14 2003-05-29 Vectabiotics Ltd Method and composition for inhibiting h.pylori infection in a mammalian tissue
EP1571920A1 (fr) * 2002-12-19 2005-09-14 Günther Beisel Preparation pour enfants destinee a reduire l'appetit, produire un effet de satiete et/ou entrainer une perte de poids
ES2708551T3 (es) * 2002-12-20 2019-04-10 Niconovum Ab Material particulado que contiene nicotina con una celulosa cristalina
ES2450133T3 (es) * 2003-01-24 2014-03-24 Stiefel Research Australia Pty Ltd Espuma de fosfato de clindamicina
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
US20070059346A1 (en) * 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
AR045061A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulacion farmaceutica y metodo para tratar trastornos gastrointestinales causados por acido
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US20050142197A1 (en) * 2003-12-31 2005-06-30 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005067941A1 (fr) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulation topique d’aciclovir
CA2554271A1 (fr) * 2004-02-10 2005-08-25 Santarus, Inc. Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien
US20050249799A1 (en) * 2004-03-03 2005-11-10 Spherics, Inc. Polymeric drug delivery system for hydrophobic drugs
CA2561700A1 (fr) * 2004-04-16 2005-12-15 Santarus, Inc. Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US20070189980A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for treating alopecia
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US20070196293A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for treating photo damaged skin
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US20070196323A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20080019927A1 (en) * 2004-06-07 2008-01-24 Jie Zhang Compositions and methods for dermally treating neuropathy with minoxidil
US20070196325A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for dermally treating infections
US20070196457A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US20070189977A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
US20070189978A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for dermally treating musculoskeletal pain
EP1616551A1 (fr) 2004-07-13 2006-01-18 L'oreal Procédé de traitement cosmétique pour prévenir ou retarder les signes du vieillissement cutané
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
JP2006151927A (ja) * 2004-12-01 2006-06-15 Toin Gakuen 光線力学的治療用組成物
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone
US20060281775A1 (en) * 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain
US20070065494A1 (en) * 2005-08-03 2007-03-22 Watson Laboratories, Inc. Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US20070042023A1 (en) * 2005-08-22 2007-02-22 National Starch And Chemical Investment Holding Corporation Dissolvable film
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
CN100394919C (zh) * 2006-03-01 2008-06-18 杨军 一种用于治疗阴道疾病的药物组合物
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
EP1998748B1 (fr) 2006-03-16 2015-01-14 NicoNovum AB Composition améliorée de tabac à priser
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
EP1897543A1 (fr) 2006-08-30 2008-03-12 Euro-Celtique S.A. Gaufre de buprénorphine pour la thérapie de substitution
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
AU2007338210B2 (en) * 2006-12-22 2013-01-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of ophthalmic drugs
US20100215774A1 (en) * 2007-02-09 2010-08-26 Todd Maibach Film comprising nitroglycerin
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
BRPI0704542B8 (pt) * 2007-05-15 2021-05-25 Univ Estadual Campinas Unicamp composição farmacêutica, processo de obtenção da composição farmacêutica, uso de uma quantidade farmaceuticamente eficaz de anestésico e agente gelificante, produto e método de tratamento
US9132296B2 (en) 2007-05-17 2015-09-15 Ag Essence Antimicrobial solution and methods of making and using the same
CN101765606A (zh) * 2007-07-27 2010-06-30 卡吉尔公司 多元醇的微粉化
JP2010538669A (ja) * 2007-09-18 2010-12-16 ニコノヴァム エービー ニコチンの迅速な放出をもたらす、マルチトールを含有する安定なチューイングガム組成物
KR101538187B1 (ko) * 2007-11-30 2015-07-22 갈데르마 리써어치 앤드 디벨로프먼트 하나 이상의 나프토산 유도체, 과산화 벤조일 및 하나 이상의 필름-형성제를 함유하는 조성물
MX347741B (es) * 2008-09-16 2017-05-10 Nektar Therapeutics Opioides pegilados con bajo potencial de abuso.
WO2010031552A1 (fr) * 2008-09-17 2010-03-25 Niconovum Ab Procédé de préparation d'une composition de tabac à priser
PL2344329T3 (pl) * 2008-10-02 2013-05-31 Mylan Inc Sposób wytwarzania wielowarstwowego laminatu przylepnego
DK2400951T3 (en) 2009-02-25 2018-12-03 Mayne Pharma Llc TOPICAL FOAM COMPOSITION
FI2442650T4 (fi) 2009-06-12 2025-08-06 Sunovion Pharmaceuticals Inc Kielen alle annettava apomorfiini
CN102665683A (zh) * 2009-10-12 2012-09-12 丽卡实验有限公司 紧急避孕药
CN102258455B (zh) * 2010-05-28 2014-09-17 上海市计划生育科学研究所 一种甾体激素类涂膜剂及其制备方法
CN101899172B (zh) * 2010-08-06 2012-01-25 北京联合大学生物化学工程学院 抑菌性可食用一次性包装膜及其制备方法
US20120107768A1 (en) * 2010-10-29 2012-05-03 Diedwardo William A Dental protective device and method of use
DK2651357T3 (da) 2010-12-16 2020-06-02 Sunovion Pharmaceuticals Inc Sublinguale film
US8936026B2 (en) 2011-02-08 2015-01-20 Orvance Technologies, Llc Orthodontic appliance shield
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
US9205037B2 (en) * 2011-07-20 2015-12-08 Church & Dwight Co., Inc. Single phase depilatory composition
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
JP5437418B2 (ja) * 2012-03-01 2014-03-12 日東電工株式会社 粘着剤組成物および粘着シート
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11547116B2 (en) 2012-12-12 2023-01-10 William Wingfield Metal oxide compounds and infusion into polymer compounds
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN103142491B (zh) * 2013-02-06 2015-07-15 广东先强药业有限公司 一种单磷酸阿糖腺苷微球给药系统及其制备方法
US20140303128A1 (en) * 2013-03-14 2014-10-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
RU2018105761A (ru) 2013-10-07 2019-02-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
CN106456561B (zh) 2013-10-07 2020-02-28 帝国制药美国公司 使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物
TWI629067B (zh) 2013-10-07 2018-07-11 美商帝國製藥美國股份有限公司 用於經皮輸送非鎮靜量右美托咪啶之方法及組成物
US8785426B1 (en) 2013-12-13 2014-07-22 Upsher-Smith Laboratories, Inc. Testosterone gel compositions and related methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
KR101741701B1 (ko) 2015-01-27 2017-05-30 대구가톨릭대학교산학협력단 변비개선용 백미 및 아마란스 혼합 발효분말의 제조방법
EP3285771B1 (fr) 2015-04-21 2025-02-12 Sunovion Pharmaceuticals Inc. Méthodes de traitement de la maladie de parkinson par l'administration d'apomorphine à une muqueuse orale
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CA3020153A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Composition pharmaceutique d'hormone steroide
WO2017173044A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne
CN106279973A (zh) * 2016-08-09 2017-01-04 凡音环保科技（苏州）有限公司 一种高分子环保薄膜
CA3038354C (fr) 2016-10-31 2021-08-17 Teikoku Pharma Usa, Inc. Procedes de gestion de la douleur a l'aide de dispositifs d'administration transdermique de dexmedetomidine
CN108130652A (zh) * 2016-12-01 2018-06-08 北京泰洋泉生物科技有限公司 一种聚乳酸无纺布及其制备方法与应用
WO2018126182A1 (fr) 2016-12-31 2018-07-05 Bioxcel Therapeutics, Inc. Utilisation de dexmédétomidine sublinguale permettant le traitement de l'agitation
CN107158453B (zh) * 2017-06-02 2020-02-18 武汉纺织大学 一种透明质酸组织粘合剂的制备方法
KR102824967B1 (ko) 2018-06-27 2025-06-25 바이오엑셀 테라퓨틱스 인코포레이티드 덱스메데토미딘을 함유하는 필름 제형 및 이를 생산하는 방법
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
CN110684361B (zh) * 2019-08-19 2021-08-20 浙江海洋大学 一种葡萄糖修饰明胶可食用保鲜膜的制备方法
CN110917345B (zh) * 2019-09-26 2021-11-09 苏州百迈生物医药有限公司 一种化疗免疫组合药物及其制备方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN111437209A (zh) * 2020-04-26 2020-07-24 华熙生物科技股份有限公司 一种自发光的光子嫩肤透明质酸保湿面膜
CN115501236B (zh) * 2022-11-09 2024-01-23 复旦大学附属肿瘤医院 一种醋酸烯诺孕酮在制备降低肺部炎症性疾病的药物中的应用
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN118384121B (zh) * 2024-06-24 2024-10-15 广州朗圣药业有限公司 左炔诺孕酮肠溶片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
NL8500774A (nl) * 1985-03-18 1986-10-16 Dagra Nv Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
US5081157A (en) * 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
DE4132005A1 (de) * 1991-09-26 1993-04-01 Merck Patent Gmbh Kombination enthaltend wachstumsfaktoren und polyelektrolyte
GB9425941D0 (en) * 1994-12-22 1995-02-22 Procter & Gamble Oral composition
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material

Also Published As

Publication number Publication date
IL162110A0 (en) 2005-11-20
US20030096012A1 (en) 2003-05-22
RU2004118487A (ru) 2005-04-20
NO20042367L (no) 2004-06-07
HUP0402280A2 (hu) 2005-09-28
HUP0402280A3 (en) 2012-07-30
WO2003043612A1 (fr) 2003-05-30
BR0214254A (pt) 2004-12-14
FR2832311A1 (fr) 2003-05-23
RU2314796C2 (ru) 2008-01-20
EP1450772A1 (fr) 2004-09-01
JP2005515185A (ja) 2005-05-26
CA2468018A1 (fr) 2003-05-30
MXPA04004791A (es) 2005-02-17
US20050042173A1 (en) 2005-02-24
PL370777A1 (en) 2005-05-30
AU2002365961A1 (en) 2003-06-10
AU2002365961B2 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
FR2832311B1 (fr) Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
FR2856685B1 (fr) Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
ZA200702131B (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof l
HUP0303825A3 (en) 1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
EP1435894A4 (fr) Composes cytoprotecteurs, procedes et formulations pharmaceutiques et cosmetiques
IS6002A (is) Pýrazólkarboxýlsýruafleiður, framleiðsla þeirra, lyfjasamsetningar sem innihalda þær
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
IL173195A0 (en) Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
MXPA03007848A (es) Derivados de quinolil propil piperidina, su preparacion y las composiciones que los contienen.
AU2002253219A1 (en) Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
DE60217783D1 (de) Filmbildende Zusammensetzung, enthaltend Sucralose und Hydrocolloid
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
NO20035035L (no) Citrasalt av 5,8,14-triazatetracyklo (10.3.1.0 opphöyet 2,11 .0 opphöyet 4,9) - heksadeca-2. (11), 3,5,7,9-pentaen og farmasöytiskesammensetninger derav
IL174479A (en) The derivatives of myastrin, pharmaceutical preparations containing them and their uses
FR2862222B1 (fr) Composition cosmetique comprenant de la gomme de gellane ou un de ses derives, un compose solide et un sel monovalent, procedes mettant en oeuvre cette composition et utilisations
DE60225775D1 (de) Zweisystem-Lackpulverzusammensetzung
HUP0401092A3 (en) 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides, preparation and use thereof
EP1911761A4 (fr) Derives d'artemisinine hydrosolubles, leurs procedes de preparation, leurs compositions pharmaceutiques et leur utilisation
IL181216A (en) 5, 3-SICO-4-NORKOLSTAN DERIVATIVES AND PHARMACEUTICAL COMPONENTS CONTAINING @ THEM
HUP0401018A3 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120731